Moreover, analysis of the CGGA, TCGA and the GSE4290 dataset indicated that EIF4A3 expression was moderately increased in lower-grade glioma (LGG) tissues but strongly elevated in GBM tissues. Here, EIF4A3 is linked to central nervous system cancer.